Danaher Corporation to acquire Abcam Plc for $24 per share in cash
CAMBRIDGE: Abcam plc (Nasdaq: ABCM), a global leader in the supply of life science research tools, has announced that its shareholders have approved the proposal...
Abcam Plc completes $340 million acquisition of BioVision
CAMBRIDGE, UK: Abcam plc, a global leader in the supply of life science research tools, has completed its acquisition of BioVision Inc from Boai NKY...
Abcam to acquire BioVision for $340 million
CAMBRIDGE, UK: Abcam plc, a global leader in the supply of life science research tools, has entered into a definitive agreement to acquire BioVision Inc.,...
Avacta Group enters into distribution agreement with ABCAM
LONDON: Avacta Group has entered into a global distribution agreement with ABCAM plcto sell the Group’s recently developed SARS-CoV-2 research ELISA Affimer reagents. Avacta has...
Abcam announces pricing of $156.5 million offering on NASDAQ
LONDON: Abcam plc, a global leader in the supply of life science research tools, announced the pricing of its offering of 8.945 million American Depositary...
Abcam announces offering and application to list on Nasdaq Global Market
LONDON: Abcam plc announced today the commencement of a registered offering of 8,945,218 American Depositary Shares (ADSs). Each ADS offered represents one ordinary share of...
Abcam Plc
Abcam Plc is a producer, distributor and seller of protein research tools. The company was founded in 1998 by Jonathan Milner with co-founders professor Tony...